title: [Daptomycin in complicated skin and soft tissue infections].
abstract: In recent years, Staphylococcus aureus, the most commonly identified infectious agent causing skin and soft tissue infections (SSTIs), has shown an increase in methicillin resistance and decreased susceptibility to vancomycin. Because of its spectrum, microbiological activity, pharmacokinetics, and safety, as well as clinical experience in its use, daptomycin seems to be a highly appropriate antibiotic in the treatment of SSTIs, especially those produced by methicillin-resistant S. aureus.
authors.affiliation: Unidad de Enfermedades Infecciosas, Hospital Central de Defensa Gómez Ulla, Madrid, España. josebarberan@teleline.es
authors.forename: José
authors.initials: J
authors.lastname: Barberán
authors.forename: M Carmen
authors.initials: MC
authors.lastname: Fariñas
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017576:Daptomycin / Q000627:therapeutic use*; D006801:Humans; D017192:Skin Diseases, Bacterial / Q000150:complications / Q000188:drug therapy*; D018461:Soft Tissue Infections / Q000150:complications / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D017576:Daptomycin